Differential regulation of PTPRK targets as a consequence of deletions/non-synonymous mutations and altered proteolytic processing correlate with observed effects of these variants on glioma cell proliferation and migration as shown in Fig. 2. The gene discussed is PTPRK; the disease is central nervous system cancer.